EN | RU
EN | RU

Help Support

Back

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis
Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Atopic dermatitis (or eczema) is one of the most common heterogeneous inflammatory skin diseases. 

See All

Attachment
Previous

Next
Risk assessment of rituximab usage and COVID-19 infection in patients with MS and NMOSD

Comments (0)

Recommendations

Read
Watch

Test the Authzero

Test 1234 Lorem Ipsum is simply dummy text of the printing and typesetting indus...

Test 140

TEST 137

Test Youtube title

AV Youtube covid-19

AV Vimeo

AV Manual

Related Tags

Next

53
Summaries

Risk assessment of rituximab usage and COVID-19 infection in patients with MS an...

Selecting a safe disease modifying therapy (DMT) during the COVID-19 is perplexing. This analytical case series study was aimed to find the incidence rate and p...

3 min More details
You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try:

This website uses cookies to help us give you the best experience when you visit.

By using this website you consent to our use of cookies. For more information please review our cookie policy.